• Mira Pharmaceuticals named Andriy Mushak fractional chief financial officer effective June 6, 2026.
• Outgoing CFO Alan Weichselbaum leaves the role June 6, 2026; departure not tied to any disagreements over operations, policies, or practices.
• Mushak is a CPA with more than 20 years of SEC reporting, accounting compliance, and audit experience.
• He is a partner at LMAM Consulting Group; previously spent over a decade at Baker Tilly US in audit, most recently as a senior manager.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mira Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-027751), on June 08, 2026, and is solely responsible for the information contained therein.